Research progress on the pathogenesis and treatment of pruritus in maintenance hemodialysis patients

doi:10.3877/cma.j.issn.2095-3216.2023.06.006

Abstract

Abstract:

Pruritus is one of the common complications of maintenance hemodialysis patients. It has a high clinical incidence, and can cause anxiety, depression, and sleep disorders, increasing the risk of mortality in the patients. Although the etiology of pruritus in maintenance hemodialysis patients is complex and unclear yet, with the continuous development of medical technology, various treatment methods have been developed to alleviate the symptoms and improve the quality of life of patients, including medication, physical therapy, and surgery, etc. This article mainly reviewed the progress of research on the pathogenesis and treatment of pruritus in maintenance hemodialysis patients.

Key words: Maintenance hemodialysis, Pruritus, Pathogenesis, Treatment

Ting Xu, Zhiqian Xiong, Liting Liu, Yan Jiang, Chaojiang Su, Zongyang Liu. Research progress on the pathogenesis and treatment of pruritus in maintenance hemodialysis patients[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(06): 334-338.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2023.06.006

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2023/V12/I06/334

Figures/Tables 1

References 38

[1]	Cheng AY, Wong LS. Uremic pruritus: from diagnosis to treatment [J]. Diagnostics (Basel), 2022, 12(5): 1108.
[2]	Sukul N, Karaboyas A, Csomor PA, et al. Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients [J]. Kidney Med, 2020, 3(1): 42-53.
[3]	Agarwal P, Garg V, Karagaiah P, et al. Chronic kidney disease-associated pruritus [J]. Toxins, 2021, 13(8): 527.
[4]	Verduzco HA, Shirazian S. CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management [J]. Kidney Int Rep, 2020, 5(9): 1387-1402.
[5]	王一梅，丁小强，陈利明，等. 190例血液透析患者皮肤瘙痒的临床研究[J]. 复旦学报(医学版), 2007, (2): 292-295.
[6]	Attia EAS, Hassan AA. Uremic pruritus pathogenesis, revisited. [J]. Arab J Nephrol Transplant, 2014, 7(2): 91-96.
[7]	Sorour NE, Elesawy FM, Tabl HA, et al. Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients [J]. Clin Cosmet Investig Dermatol, 2019, 12: 109-114.
[8]	Wieczorek A, Krajewski P, Kozioł-Gałczyńska M, et al. Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus [J]. J Eur Acad Dermatol Venereol, 2020, 34(10): 2368-2372.
[9]	王楠，林洪丽. 透析模式对血液透析患者预后影响的思考[J]. 中国实用内科杂志，2021, 41(11): 926-930.
[10]	Reszke R, Kilis-Pstrusińska K, Szepietowski JC. Chronic kidney disease-associated itch (CKD-aI) in children-a narrative review [J]. Toxins (Basel), 2021, 13(7): 450.
[11]	Weisshaar E, Szepietowski JC, Dalgard FJ, et al. European S2k guideline on chronic pruritus [J]. Acta Derm Venereol, 2019, 99(5): 469-506.
[12]	Tang Y, Cheng S, Wang J, et al. Acupuncture for the treatment of itch: peripheral and central mechanisms [J]. Front Neurosci, 2022, 15: 786892.
[13]	Xiong W, He FF, You RY, et al. Acupuncture application in chronic kidney disease and its potential mechanisms [J]. Am J Chin Med, 2018, 46(6): 1169-1185.
[14]	刘东，高卓，魏学明，等. 甲状旁腺切除治疗尿毒症继发性甲状旁腺功能亢进症患者皮肤瘙痒的临床观察[J]. 中国血液净化，2014, 13(3): 134-136.
[15]	Martin CE, Clotet-Freixas S, Farragher JF, et al. Have we just scratched the surface? A narrative review of uremic pruritus in 2020 [J]. Can J Kidney Health Dis, 2020, 7: 2054358120954024.
[16]	Krajewski PK, Olczyk P, Krajewska M, et al. Clinical characteristics of itch in renal transplant recipients [J]. Front Med (Lausanne), 2021, 7: 615334.
[17]	Teo WY, Chu SWF, Chow LY, et al. Role of alternative medical systems in adult chronic kidney disease patients: a systematic review of literature [J]. Cureus, 2022, 14(12): e32874.
[18]	Makhlough A, Ala S, Haj-Heydari Z, et al. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis [J]. Iran J Kidney Dis, 2010, 4(2): 137-140.
[19]	Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus [J]. Clin Pharmacokinet, 1995, 29(6): 404-430.
[20]	Chen YC, Chiu WT, Wu MS. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus [J]. Am J Kidney Dis, 2006, 48(1): 69-76.
[21]	Szepietowski JC, Szepietowski T, Reich A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study [J]. Acta Dermatovenerol Croat, 2005, 13(2): 97-103.
[22]	张萍，宋小炜，杨丽南，等. 丝胶蛋白对维持性血液透析患者尿毒症性瘙痒疗效的研究[J]. 西南国防医药，2017, 27(3): 221-223.
[23]	Kobayashi K, Endoh F, Ohmori I, et al. Action of antiepileptic drugs on neurons [J]. Brain Dev, 2020, 42(1): 2-5.
[24]	Eusebio-Alpapara KMV, Castillo RL, Dofitas BL. Gabapentin for uremic pruritus: a systematic review of randomized controlled trials [J]. Int J Dermatol, 2020, 59(4): 412-422.
[25]	Ravindran A, Kunnath RP, Sunny A, et al. Comparison of safety and efficacy of pregabalin versus gabapentin for the treatment of uremic pruritus in patients with chronic kidney disease on maintenance haemodialysis [J]. Indian J Palliat Care, 2020, 26(3): 281-286.
[26]	Zhang P, Xiang S, Liu B, et al. Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients [J]. Ren Fail, 2023, 45(1): 2175590.
[27]	Wala K, Szepietowski JC. Difelikefalin in the treatment of chronic kidney disease-associated pruritus: a systematic review [J]. Pharmaceuticals (Basel), 2022, 15(8): 934.
[28]	Fishbane S, Jamal A, Munera C, et al. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus [J]. N Engl J Med, 2020, 382(3): 222-232.
[29]	Peer G, Kivity S, Agami O, et al. Randomised crossover trial of naltrexone in uraemic pruritus [J]. Lancet, 1996, 348(9041): 1552-1554.
[30]	Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study [J]. J Am Soc Nephrol, 2000, 11(3): 514-519.
[31]	Mathur VS, Kumar J, Crawford PW, et al. A multicenter, randomized, double-blind, placebo-controlled trial of nalbuphine ER tablets for uremic pruritus [J]. Am J Nephrol, 2017, 46(6): 450-458.
[32]	Pakfetrat M, Malekmakan L, Hashemi N, et al. Sertraline can reduce uremic pruritus in hemodialysis patient: a double blind randomized clinical trial from Southern Iran [J]. Hemodial Int, 2018, 22(1): 103-109.
[33]	Mettang T, Krumme B, Bohler J, et al. Pentoxifylline as treatment for uraemic pruritus--an addition to the weak armentarium for a common clinical symptom? [J]. Nephrol Dial Transplant, 2007, 22(9): 2727-2728.
[34]	Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease [J]. Cochrane Database Syst Rev, 2020, 12(12): CD011393.
[35]	Forouhari A, Moghtaderi M, Raeisi S, et al. Pruritus-reducing effects of omega-3 fatty acids in hemodialysis patients: a cross-over randomized clinical trial [J]. Hemodial Int, 2022, 26(3): 408-414.
[36]	Cupisti A, Piccoli GB, Gallieni M. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease [J]. Curr Opin Nephrol Hypertens, 2020, 29(1): 71-79.
[37]	禤晓燕，李杰峰，梁子安，等. 硫代硫酸钠治疗维持性血液透析患者皮肤瘙痒的研究 [J]. 黑龙江医学，2019, 43(5): 474-475.
[38]	Song YH, Wang SY, Lang JH, et al. Therapeutic effect of intravenous sodium thiosulfate for uremic pruritus in hemodialysis patients [J]. Ren Fail, 2020, 42(1): 987-993.

Please choose a citation manager

Content to export